What is the recommended dose of cefuroxime (Cefuroxime) for pediatric patients with bacterial infections, considering age and weight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing of Cefuroxime for Bacterial Infections

For pediatric patients with bacterial infections, administer cefuroxime intravenously at 20-30 mg/kg every 8 hours (three times daily) for children over 1 month of age, with higher doses of 30 mg/kg every 8 hours reserved for severe infections. 1, 2

Age-Specific Dosing Algorithm

Neonates (≤1 month)

  • <7 days old: 30 mg/kg every 12 hours (twice daily) 1
  • >7 days old: 30 mg/kg every 8 hours (three times daily) 1

Infants and Children (>1 month to 18 years)

  • Standard dosing: 20-30 mg/kg every 8 hours IV 1, 2
  • Severe infections: 30 mg/kg every 8 hours (up to maximum adult dose of 1.5 grams per dose) 1, 2
  • Maximum daily dose: Do not exceed 6 grams per day total 2

Route-Specific Considerations

Intravenous Administration

  • Preferred route for severe infections, bacteremia, or critically ill patients 2
  • Administer over 3-5 minutes for direct IV push, or as intermittent infusion 2
  • Dosing frequency is every 8 hours (three times daily) for most infections 1, 2

Oral Administration (Cefuroxime Axetil)

  • 1-24 months: 125 mg twice daily 1
  • 2-12 years: 250 mg twice daily 1
  • Oral formulation is less reliably absorbed and may not achieve adequate tissue penetration for serious infections 3

Infection-Specific Dosing Guidance

Community-Acquired Pneumonia

  • 75 mg/kg/day divided every 8 hours (25 mg/kg per dose) has demonstrated excellent efficacy 4, 5
  • This regimen successfully treated pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus 5
  • Clinical response typically occurs within 3 days, with complete resolution of respiratory symptoms by day 5 5

Soft Tissue Infections and Cellulitis

  • 75 mg/kg/day divided every 8 hours (25 mg/kg per dose) 4
  • Effective for preseptal cellulitis, buccal cellulitis, and bacteremic soft tissue infections 4
  • All patients in clinical trials showed satisfactory response with this dosing 4

Severe or Life-Threatening Infections

  • Use the higher end of the dosing range: 30 mg/kg every 8 hours 1, 2
  • Consider increasing frequency to every 6 hours if infection is due to less susceptible organisms 2

Critical Dosing Pitfalls to Avoid

Do not underdose severe infections: The range of 20-30 mg/kg exists, but 20 mg/kg is appropriate only for mild-to-moderate infections 1. For hospitalized children or documented severe bacterial infections, always use 30 mg/kg every 8 hours 1, 2.

Do not use oral formulation for serious infections: Cefuroxime axetil (oral) shows variable absorption and may not achieve adequate tissue concentrations, particularly in respiratory infections 3. Reserve oral therapy for mild infections or step-down therapy after IV treatment 1.

Adjust for renal impairment: In pediatric patients with renal insufficiency, modify dosing frequency consistent with adult recommendations, though specific pediatric renal dosing guidelines are limited 2.

Avoid in meningitis: Cefuroxime does not achieve adequate CSF penetration and should not be used for bacterial meningitis 2. Use ceftriaxone or cefotaxime instead for CNS infections.

Practical Dosing Examples

  • 10 kg child with pneumonia: 250 mg IV every 8 hours (25 mg/kg/dose) 4, 5
  • 20 kg child with severe cellulitis: 600 mg IV every 8 hours (30 mg/kg/dose) 1, 4
  • 30 kg child with bacteremia: 900 mg IV every 8 hours (30 mg/kg/dose) 1, 2

Duration of Therapy

  • Most bacterial infections: 7-10 days 1
  • May extend to 14 days depending on clinical response and severity 1
  • Continue therapy for minimum 48-72 hours after patient becomes afebrile or shows bacterial eradication 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical trial of cefuroxime axetil in children.

The Journal of antimicrobial chemotherapy, 1987

Research

Cefuroxime therapy for bacteremic soft-tissue infections in children.

American journal of diseases of children (1960), 1985

Research

Cefuroxime therapy for pneumonia in infants and children.

Pediatric infectious disease, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.